Funds holding Climb Bio Inc
ISIN US28658R1068 · United States
- Fund holders
- 31
- Of which ETFs
- 4 27 other funds
- Value held
- ≈ 24.5M $ 24.1M $ · 272.3K €
- Share of capital
- 6.0 % of 57.4M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 1,468,417 | 10.1M $ | 0.09 % | 2.56 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 854,986 | 5.9M $ | 0.00 % | 1.49 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 292,909 | 2M $ | 0.00 % | 0.51 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 137,157 | 980.7K $ | 0.00 % | 0.24 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 93,200 | 638.4K $ | 0.10 % | 0.16 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 77,914 | 533.7K $ | 0.04 % | 0.14 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 73,800 | 505.5K $ | 0.41 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 56,340 | 500.3K $ | 0.00 % | 0.10 % | as of Apr 30, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 50,000 | 342.5K $ | 0.40 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 46,916 | 335.4K $ | 0.00 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 38,800 | 265.8K $ | 0.12 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 37,606 | 268.9K $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 36,884 | 263.7K $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 32,453 | 222.3K $ | 0.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 30,827 | 273.7K $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 27,800 | 190.4K $ | 0.12 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 22,000 | 195.4K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 17,962 | 159.5K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 16,894 | 115.7K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 13,870 | 95K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 10,016 | 68.6K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 8,176 | 72.6K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 5,644 | 38.7K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 5,000 | 34.3K $ | 0.00 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 4,981 | 44.2K $ | 0.00 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 4,805 | 42.7K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 1,700 | 11.6K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 1,661 | 14.7K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,153 | 7.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 165 | 1.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 272.3K € | 0.33 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| Ultra-Small Company Market Fund Bridgeway Funds, Inc. | 0.41 % | as of Mar 31, 2026 ↗ |
| Ultra-Small Company Fund Bridgeway Funds, Inc. | 0.40 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.33 % | as of Dec 31, 2025 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.12 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 0.12 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 0.10 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 0.09 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.04 % | as of Mar 31, 2026 ↗ |
| 1290 VT Micro Cap Portfolio EQ Advisors Trust | 0.02 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 0.02 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 30 | +4 | 3,470,036 | +4.4 % |
| 2026Q1 | 26 | +5 | 3,323,288 | +36.4 % |
| 2025Q4 | 21 | -24 | 2,436,304 | -1.3 % |
| 2025Q3 | 45 | -39 | 2,469,121 | -39.4 % |
| 2025Q2 | 84 | +4 | 4,076,244 | +2.1 % |
| 2025Q1 | 80 | +3 | 3,991,805 | +22.1 % |
| 2024Q4 | 77 | +42 | 3,270,611 | +489.6 % |
| 2024Q3 | 35 | +25 | 554,719 | +26.4 % |
| 2024Q2 | 10 | 0 | 438,826 | -0.1 % |
| 2024Q1 | 10 | 0 | 439,394 | +0.7 % |
| 2023Q4 | 10 | 436,346 |
Institutional managers
76 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11,300,939 | 77.4M $ | as of Mar 31, 2026 |
| MPM BIOIMPACT LLC | 2,593,439 | 17.8M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,916,968 | 13.1K $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 1,529,675 | 10.5M $ | as of Mar 31, 2026 |
| GREAT POINT PARTNERS LLC | 1,334,130 | 9.1M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,276,260 | 8.7M $ | as of Mar 31, 2026 |
| Kynam Capital Management, LP | 1,003,341 | 6.9M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 773,123 | 5.3M $ | as of Mar 31, 2026 |
| Affinity Asset Advisors, LLC | 700,000 | 4.8M $ | as of Mar 31, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 684,908 | 4.7M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 600,946 | 4.1M $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 597,662 | 4.1M $ | as of Mar 31, 2026 |
| NAN FUNG TRINITY (HK) LTD | 420,517 | 2.9M $ | as of Mar 31, 2026 |
| SPHERA FUNDS MANAGEMENT LTD. | 419,247 | 2.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 401,649 | 2.8M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 387,403 | 2.7M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 345,663 | 2.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 312,999 | 2.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 310,606 | 2.1M $ | as of Mar 31, 2026 |
| DIADEMA PARTNERS LP | 286,126 | 2M $ | as of Mar 31, 2026 |
| TD Asset Management Inc | 250,102 | 1.7M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 234,182 | 1.6M $ | as of Mar 31, 2026 |
| Longaeva Partners L.P. | 217,768 | 1.5M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 217,300 | 1.5M $ | as of Mar 31, 2026 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 199,209 | 1.4M $ | as of Mar 31, 2026 |
Declared shareholders of Climb Bio Inc
1 beneficial ownership filing. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RA Capital Management, L.P. and 5 others | 33.00 % | 22,631,401 | as of Apr 27, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding Climb Bio Inc". https://titelia.com/en/stocks/climb-bio-inc-US28658R1068